<SEC-DOCUMENT>0001104659-11-048330.txt : 20110823
<SEC-HEADER>0001104659-11-048330.hdr.sgml : 20110823
<ACCEPTANCE-DATETIME>20110823150329
ACCESSION NUMBER:		0001104659-11-048330
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20110819
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20110823
DATE AS OF CHANGE:		20110823

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO KEY INTERNATIONAL INC
		CENTRAL INDEX KEY:			0001019034
		STANDARD INDUSTRIAL CLASSIFICATION:	COMPUTER COMMUNICATIONS EQUIPMENT [3576]
		IRS NUMBER:				411761861
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13463
		FILM NUMBER:		111051925

	BUSINESS ADDRESS:	
		STREET 1:		3349 HIGHWAY 138
		STREET 2:		BUIDING D, SUITE B
		CITY:			WALL
		STATE:			NJ
		ZIP:			07719
		BUSINESS PHONE:		6516870414

	MAIL ADDRESS:	
		STREET 1:		3349 HIGHWAY 138
		STREET 2:		BUIDING D, SUITE B
		CITY:			WALL
		STATE:			NJ
		ZIP:			07719

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SAC TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19961115
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a11-24861_18k.htm
<DESCRIPTION>8-K
<TEXT>


<html>
<head>

  </head>
<body lang="EN-US">
<div style="font-family:Times New Roman;">
<div style="border-bottom:solid windowtext 1.0pt;border-left:none;border-right:none;border-top:solid windowtext 3.0pt;padding:1.0pt 0in 1.0pt 0in;">
<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">UNITED STATES</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Washington, D.C. 20549</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">FORM&nbsp;8-K</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">CURRENT REPORT</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">Pursuant to Section&nbsp;13 or 15(d)&nbsp;of the Securities Exchange Act of 1934</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of Report (Date of earliest event reported): <b>August&nbsp;19, 2011</b></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">BIO-key International,&nbsp;Inc.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Exact name of registrant as specified in its charter)</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Delaware</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(State or other jurisdiction of<br>   incorporation)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">1-13463</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Commission File Number)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">41-1741861</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(I.R.S. Employer Identification No.)</font></p>    </td>   </tr>  </table>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">3349 Highway 138, Building D, Suite&nbsp;B</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Wall, NJ 07719</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Address of principal executive offices)</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(732)&nbsp;359-1100</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Registrant&#146;s telephone number, including area code)</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check the appropriate box below if the Form&nbsp;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<i>see</i> General Instruction A.2 below):</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Pre-commencement communications pursuant to Rule&nbsp;14d-2(b)&nbsp;under the Exchange Act (17 CFR 240.14d-2(b))</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Pre-commencement communications pursuant to Rule&nbsp;13e-4(c)&nbsp;under Exchange Act (17 CFR 240.13e-4(c))</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="border-bottom:solid windowtext 3.0pt;border-left:none;border-right:none;border-top:solid windowtext 1.0pt;padding:1.0pt 0in 1.0pt 0in;">
<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\106750\11-24861-1\task4844445\24861-1-ba.htm',USER='106750',CD='Aug 23 21:39 2011' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 7.01.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Results of Operations and Financial Condition.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On August&nbsp;19, 2011, BIO-key International,&nbsp;Inc. (the &#147;Company&#148;) issued a press release as the result of an incorrect &#147;dial in&#148; number for its second quarter ended June&nbsp;30, 2011 conference call which is included as an exhibit to a Current Report on Form&nbsp;8-K.&nbsp;A copy of the press release issued by the Company on August&nbsp;19, 2011 is attached as Exhibit&nbsp;99.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:49.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The information, including the exhibit attached hereto, in this Current Report on Form&nbsp;8-K shall not be deemed &#147;filed&#148; for purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as otherwise expressly stated in such filing.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 9.01.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Financial Statements, Pro Forma Financial Information and Exhibit.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Exhibits</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Press Release, dated August&nbsp;19, 2011, issued by </font><font size="2" style="font-size:10.0pt;">the Company.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2<a name="PB_2_211351_7056"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\106750\11-24861-1\task4844445\24861-1-ba.htm',USER='106750',CD='Aug 23 21:39 2011' -->

<br clear="all" style="page-break-before:always;">
<div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SIGNATURES</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIO-KEY INTERNATIONAL,&nbsp;INC.</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.44%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.56%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date: August&nbsp;23, 2011</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.44%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.56%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.44%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.56%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.44%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="45%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:45.56%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Cecilia C. Welch</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.44%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:45.56%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cecilia   C. Welch</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.44%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.56%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Chief   Financial Officer</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3<a name="PB_3_211454_5335"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='3',FILE='C:\JMS\106750\11-24861-1\task4844445\24861-1-ba.htm',USER='106750',CD='Aug 23 21:39 2011' -->

<br clear="all" style="page-break-before:always;">
<div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EXHIBIT&nbsp;INDEX</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="11%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.12%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Exhibit&nbsp;No.</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="86%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:86.66%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Description</font></b></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:11.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="86%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:86.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="11%" valign="top" style="padding:0in 0in 0in 0in;width:11.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.1</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="86%" valign="top" style="padding:0in 0in 0in 0in;width:86.66%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Press   Release, dated August&nbsp;19, 2011,   issued by the Company.</font></p>    </td>   </tr>  </table>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4<a name="PB_4_211536_5796"></a></font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='4',FILE='C:\JMS\106750\11-24861-1\task4844445\24861-1-ba.htm',USER='106750',CD='Aug 23 21:39 2011' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a11-24861_1ex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>


<html>
<head>

  </head>
<body lang="EN-US">
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 99.1</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
<tr>
<td width="67%" valign="top" style="padding:0in 0in 0in 0in;width:67.78%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman"><img width="192" height="144" src="g248611mmi001.jpg" alt="GRAPHIC"></font></p>    </td>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Contacts:</font></p>    </td>
<td width="22%" valign="top" style="padding:0in 0in 0in 0in;width:22.22%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIO-key   International,&nbsp;Inc.</font></u><font size="2" style="font-size:10.0pt;"> Scott Mahnken </font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">732-359-1113</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in .1in .0001pt 0in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On Monday, August&nbsp;15</font><font size="1" style="font-size:6.5pt;position:relative;top:-3.0pt;">th</font><font size="2" style="font-size:10.0pt;">&#160;2011 during our second quarter earnings conference call we shared the news of the SIC Acquisition but an incorrect &#147;dial in&#148; number in our announcement and press release resulted in many callers being unable to connect and join the questions and answers session.&#160; Therefore, we felt it was imperative to open the discussion to a national audience and add more detail in the following Frequently Asked Question Summary. We are forecasting an enthusiastic response from new and existing customers as we introduce our new full and complete biometric fingerprint solutions for the iPad, iPhone and iPod and welcome any questions or comments that you may have.&#160; Please feel free to call or write at the following (866) 846-2594 or (732) 359-1100 or <b>info@bio-key.com</b></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Why does BIO-key consider the potential acquisition of S.I.C. to be the most compelling event in the company&#146;s history?</font></i></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">There are several reasons:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Our customers are seeking a <b><u style="font-weight:bold;">total solution</u></b> and prefer establishing a single relationship with one vendor that can address all of their biometric security requirements.&#160; Adding the S.I.C. product line diversifies our selection of products and services allowing us to compete for more projects moving forward.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Secondly the <b><u style="font-weight:bold;">mobile market</u></b> is<b>  </b>vast and growing and the need for biometric solutions is burgeoning. Thus the fundamental inspiration for this acquisition is to pioneer the integration of biometric solutions for advanced mobile devices.&#160; The market demand for technology &#151; security and convenience must be addressed and we believe BIO-key is very well positioned to champion the effort.&#160; Physicians have embraced the iPad yet don&#146;t embrace having to input tedious sophisticated passwords upon entering each transaction.&#160; In the commercial / retail space we have witnessed an epidemic of security breaches and this too presents tremendous opportunities for biometric solutions.&#160; Providers already have the technology to introduce mobile banking, but they have yet to identify the best way to secure such transactions.&#160; Lastly we believe offering an innovative solution today for <b><u style="font-weight:bold;">Apple </u></b>products puts us in a highly competitive, leadership position and will enable BIO-key to grow exponentially.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105586\11-24861-1\task4844536\24861-1-mm.htm',USER='105586',CD='Aug 23 22:20 2011' -->

<br clear="all" style="page-break-before:always;">
<div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">When does BIO-key expect to finalize and close the transaction?</font></i></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">It is expected that the Definitive Agreements will be executed and the acquisition will be complete by the end of September&nbsp;or early October&nbsp;pending normal and customary regulatory items.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Will BIO-key be seeking to raise additional capital to fund the acquisition?</font></i></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIO-key will likely attempt to secure debt financing to insure the proper level of working capital to manufacture the product, conduct national marketing campaigns and align with a world class advertising agency, as well as increase our sales footprint.&#160; With our clean balance sheet and cap table we don&#146;t see an issue in doing so and more importantly doing it without any significant dilution.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">How will the transaction be financed?</font></i></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The purchase price will be largely accomplished with BIO-key stock and earnouts based on product performance. Not accounting for additional financing and given the retirement of some 20 million warrants during the past year, we believe the number of fully diluted shares outstanding post transaction will be generally consistent with our capital structure of late last year.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Who will be in charge moving forward; what will the management team look like?</font></i></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The leadership team will remain intact.&#160; Mike DePasquale will remain as the Company&#146;s CEO.&#160; Eric Talbot, President / CEO of S.I.C. Biometrics will become Vice President of BIO-key&#146;s Mobility Division.&#160;&#160; The current team of Randy Fodero VP Sales and Scott Mahnken VP Marketing will also remain and will assume responsibility for the same functions in the integrated company.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">How will the S.I.C. employees integrate?</font></i></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The remaining employees of S.I.C. will continue to fulfill the responsibilities of their positions and Eric will be adding resources within the Mobility Division to enhance our sales, support, engineering and design capabilities.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Will the newly formed company still maintain operations in Canada and France &#151; what about manufacturing?</font></i></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We will continue to operate in Canada and will also inherit a sales office outside of Paris, France that will become our European Headquarters and will cover the European and Middle-East markets. Current plans are to continue to manufacture products in Canada while seeking additional options in anticipation of increasing demand.&#160; We may also source US manufacturing capability depending on technology and business factors.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Is BIO-key considering a reverse stock split?</font></i></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Although there are both potential positive and negative outcomes of a reverse stock split,</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105586\11-24861-1\task4844536\24861-1-mm.htm',USER='105586',CD='Aug 23 22:20 2011' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">at the time of this announcement a reverse split is not being considered.&#160; As we have declared a number of times it will only be done from a position of strength and to enhance our currency so additional investors can participate in the upside potential that BIO-key presents.&#160; When the share price rises to that appropriate level perhaps it will once again be considered.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">What happened to the unnamed international deal?</font></i></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Our partner who secured the contract is experiencing minor delays in deployment due to the typical and expected unstable nature of third world environments.&#160; Any company dealing in that venue experiences these issues but for sure the project is still moving forward and the integration and deliverables BIO-key is responsible for have been executed.&#160; Although we are disappointed with the delays and the extension of revenue potential out to future quarters we have experienced similar issues in the past.&#160; Some might say it is the price one pays when dealing with international government and its bureaucracy.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">How can we use the term &#151; leader, pioneer, or revolutionary?</font></i></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">LEADERSHIP<br>  </font></b><font size="2" style="font-size:10.0pt;">There are very few companies in the biometric industry that can trace their roots back to 1993.&#160; BIO-key has supported many facets of business and industry including introducing key biometric security with its former law enforcement division.&#160; Today, BIO-key software is interoperable with virtually every fingerprint reader on the market an achievement that no other company can claim. BIO-key software is award winning and the BIO-key algorithm has tested to one of the fastest and most accurate.&#160;&#160; Our accomplishments have helped us build relationships with marquee clients such as the FBI &#151; AT&amp;T &#151; IBM - LexisNexis and many others.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">PIONEERS</font></b><font size="2" style="font-size:10.0pt;"><br> BIO-key is the first company to offer such vast interoperability.&#160; BIO-key has a history of developing biometric technology during the days when it wasn&#146;t as widely recognized and today we are spearheading the campaign to bring the security and convenience of fingerprint biometrics to advanced mobile devices such as the smartphone and tablet.&#160; Yes&#133;..we are pioneers.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">REVOLUTIONARY</font></b><font size="2" style="font-size:10.0pt;"><br> There is already a revolution; we just want to be part of it.&#160; The mobility revolution has been evolving during the past ten years and with the introduction of Tablets and Smartphone&#146;s the momentum is unstoppable.&#160; Although the developers have dedicated countless hours to developing advanced applications and functionality little time or money has been invested in the security and identification process.&#160; If your phone has the ability to make an online purchase, transfer funds from checking to savings, review your important work files and documents doesn&#146;t it require the strongest security available?</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105586\11-24861-1\task4844536\24861-1-mm.htm',USER='105586',CD='Aug 23 22:20 2011' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Is Management aligned with the interest of our common shareholders??</font></i></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Very much so! While we are deeply disappointed with our present stock price and the lack of more significant revenue traction, the management team is proud of what it has been able to accomplish. With marginal resources relative to its competitors and operating in a market space that has had almost no demand for biometrics in the past, the company has been able to survive, while others have failed. Through incredible sustained effort and creativity we have eliminated $16 million of debt, thus creating substantial shareholder value. We have taken a company with embryonic biometric science and created one of the leading finger biometric products on the market &#151; the technology is so accurate, scalable and robust that it is the core technology used by the FBI in its Next Generation Identification program.&#160; Every single employee at BIO-key receives part of their compensation in the form of stock options and the value of those options is totally dependent on our performance and ultimately the price of our shares.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">These accomplishments have now positioned us for this acquisition that has the potential to alter the market for security on mobile devices, especially on the Apple platforms.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">What is the impartial / analysts view of the market potential in Mobility and is it the perfect storm for biometrics?</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Analyst Forecasts</font></i></b></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Gartner forecasts 428 million Smartphone&#146;s will be sold in 2011.&#160; The Gartner forecast for 2012 is 630 million units and by 2015 the number reaches 1.1 billion units.</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Gartner forecasts 2011 iPhone sales to be 90,560,000 units</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">J.P. Morgan forecasts 2011 iPad sales to be 31,000,000 units</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">The iPad is outselling the competition at a staggering rate of 24-1according to The Next Web</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Barron&#146;s forecast 2012 iPad sales to be 48 million units</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Needham analyst Charlie Wolf forecasts 233 million tablets will be sold in 2020 and predicts that Apple will own 60% of the market or 139,800,000 units sold</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Acuity Intelligence forecast that 87% of all Passports and Visa&#146;s will be electronic ePassports and eVisas</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">When will S.I.C. generate revenue?</font></i></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">S.I.C. already generates revenue as witnessed by the announcement of a contact with one of Canada&#146;s leading hospitals.&#160; The contact is worth $1.5 USD.&#160; The current S.I.C. pipeline will generate revenue for BIO-key beginning in our fourth calendar quarter.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105586\11-24861-1\task4844536\24861-1-mm.htm',USER='105586',CD='Aug 23 22:20 2011' -->

<br clear="all" style="page-break-before:always;">
<div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">How can I listen to the recorded earnings and announcement conference call?</font></i></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dial (877) 344-7529 or (412) 317-0088 and use the access code 452169#</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">About S.I.C. Biometrics</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">S.I.C Biometrics Inc. located in Montreal Canada, develops and manufacturers biometric plug-in mobile fingerprint scanners, biometric proximity cards and access control solutions.&#160; S.I.C. Biometrics through direct collaboration with Apple in 2009 is credited with developing the first fingerprint reader for the Apple iPad and iPhone.&#160; The S.I.C platform of identification solutions is interoperable and can be utilized with most existing infrastructures providing an optimum return on your investment. The company model of manufacturing simple and convenient turn-key solutions enables secure access to any IT application using state of the art finger biometric technology and is championed by S.I.C&#146;s FMID mobile solution product line. (<b>http://www.sicbiometrics.com</b>)</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">About BIO-key</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIO-key International,&nbsp;Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers.&nbsp;BIO-key&#146;s award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world&#146;s largest identification deployments to improve security, guarantee identity, and help reduce identity theft.&nbsp;&nbsp;BIO-key&#146;s technology is offered directly or by market leading partners around the world. (<b>http://www.bio-key.com</b>)</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BIO-key Safe Harbor Statement</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Certain statements contained in this press release may be construed as &#147;forward-looking statements&#148; as defined in the Private Securities Litigation Reform Act of 1995 (the &#147;Act&#148;).&nbsp; The words &#147;estimate,&#148; &#147;project,&#148; &#147;intends,&#148; &#147;expects,&#148; &#147;anticipates,&#148; &#147;believes&#148; and similar expressions are intended to identify forward-looking statements.&nbsp; Such forward-looking statements are made based on management&#146;s beliefs, as well as assumptions made by, and information currently available to, management pursuant to the &#147;safe-harbor&#148; provisions of the Act.&nbsp; These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements.&nbsp; These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, our ability to attract and retain key personnel and our ability to complete the proposed acquisition of S.I.C. Biometrics Inc. as currently planned.&nbsp; For a more complete description of these and other risk factors that may affect the future performance of BIO-key International,&nbsp;Inc., see &#147;Risk Factors&#148; in the Company&#146;s Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2010 and its other filings with the Securities and Exchange Commission.&nbsp; Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made.&nbsp; The Company also undertakes no obligation to disclose any revision to</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105586\11-24861-1\task4844536\24861-1-mm.htm',USER='105586',CD='Aug 23 22:20 2011' -->

<br clear="all" style="page-break-before:always;">
<div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\105586\11-24861-1\task4844536\24861-1-mm.htm',USER='105586',CD='Aug 23 22:20 2011' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g248611mmi001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g248611mmi001.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!#`0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P``1"`"0`,`#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#V7-&:**`#
M-&:*0D`$G@"@!<T9KD-?^(^DZ2S06A^WW*\;8CA%/NW^&:\]U?QUK^L%E>[-
MK"?^65O\HQ[GJ:PGB(1TW.^AE]:KK:R\SV+4->TG2A_IVH6\!_NLXW?EUKG;
MOXH^'K<D0?:;HC_GG'@?FV*\=)R2S')/4D\UHZ=X?UC5L?8=.GF4_P`>W"_F
M>*YGB9R^%'I1RNA35ZLOT.[F^+L7_+#1I#[R3`?R!J#_`(6[<?\`0&C_`._Y
M_P`*S[/X5Z[.`;F>UM0>Q8N?TX_6M:'X0IC]_K3Y](X`/YFFGB&2UEL-'K]X
MR/XO/G][HHQ_L3_XBM&U^+.CR$"YLKN#W`5Q^AJ$?"/3\<ZK=D_[BU!-\(8\
M?N-:<'TD@!_D:I?6$9/^S9=U]YU5AXU\.ZD0L&IQ*Y_@E_=G]:W%=74,I#*>
MA!R#7DEY\*=:A!-O<VER/[I)0_KQ68L/C#P@^]$O+6-3SC]Y$?J.15^VG'XX
MF;P5"I_!J+T?]?H>WYHS7G6@_%2&4K#K<`A)X^T0C*_BO4?AFN_M;J"]MTN+
M:9)HG&5=&R#6\*D9[,X*V'J47::)LT9HHJS`,T9HHH`,T9HHH`,T44"@`HHK
M+\0:]:>'M,>]NVR>D<8/S2-Z"DVDKLJ,7)J,=R76-:L-#L6N[^81H.%'5G/H
M!W->1>)O'6I>(&:"(M:6/:%&^9Q_M'O].E9.MZY?:_J#7E[)D](XQ]V-?051
MBBDGE2*)&DD<[511DL?05YU6NYNT=CZ3"8"%%<]367X(9P!Z"NE\.^!=6\0!
M9MOV2T/_`"WE'WA_LKW_`)5V'A+X<P62QWVMHL]S]Y;<\I']?[Q_2N]``&!P
M!T%72PU]9F&*S2SY:/W_`.1S6B^`M"T8*_V;[7<#_EK<?-S[#H*Z4`*````.
M@%+17;&*BK)'ASJ3J.\W<****H@**@N[RVL8#/=W$<$2]7D8**Y/4/BCH-HQ
M2V$]ZP[QKM7\S42G&.[-:=&I5^"-SLZ3J,=J\X_X6Q-.W^B:!)*/^NI8_HM6
M(_B=<Q\WGAJ\C7NR$_U45'MX=SH>`Q"WC^*-W6_`NAZT&=K86UP?^6UOA3GW
M'0UQ,FE^)_AY<M=V3_:]/)S)M!*$?[2_PGW%=GI?Q!\/:HXB%V;68\>7<C9S
M]>GZUTGRR+V96'U!%)PA/WHO7R*C7K4/<JJZ[/\`0Q_#?BBP\2V?G6K;)4'[
MV!C\R'^H]ZVJX/Q#X-N-,O/[?\+?N+J(EI+9/NN.^T?^R]^U=%X8\16_B33!
M<QCRYD.V>$GF-O\`#TJH2=^66YE6I1Y?:4OA_%>IM4445J<H4444`%`HH%`$
M5S<16EM)<3N(XHE+NQZ`"O"O%'B*?Q)J[W3Y6!,K!$?X%]?J>IKMOBGKQBMX
M=$@?YIAYD^/[H/"_B>?PKS"O/Q-2[Y$?0Y7AE&/MI;O84`D@`$D\`#O7K_@3
MP8FBVZZC?Q@ZA*N0#_RP4]A[^OY5S/PS\-KJ&H-J]U'N@M&Q$".&D]?P_F:]
M&O?$>AZ:=M[K%E;L.JR3J#^6:O#4OMLRS/%N_L8/U_R-+%+619^+?#FH2B&T
MURPFD/`1;A<G\,UKYQUKM/#"BJ1UG2@<'4[//_7=?\:GM[RUNPQM;F&<+][R
MI`V/RH`FKE?&/C6#PW']F@59]0D7*QD_+&/[S?X5U)KR'6O#=M_PE,]QK'B7
M38;268R/(]RHEVY^[M]<<>E957-+W#KPD:,IWK.R7XE*PTGQ#X^OS<3SLT2M
MAIY?]7'[*OK["O0M'^'F@Z6JM-;_`&Z<=9+CD9]EZ"M70[_09K..UT2]LYH8
MEPJ6\JM@?0&M6IA1C'5ZLNOCJE3W8>['LAD4$4"!(8DC4=%10!^E/HHK<X3.
MU'P_I&K1E+[3H)L_Q%`&'XCFL)='U7PF?.T:674-.',FGS-ET'K&W]#74W-U
M;V<#3W4\<$2_>DD<*H_$TL$\-U`D]O*DL4@W)(C!E8>H(J'!/7J:QK2BN5ZK
ML0:?J%MJEE'>6DF^*0<'&"#W!'8CTKE=?L7\+ZROBG3D/V=R$U*!!PRD_?`]
M1_GO6TUL-(UP7,`VVNH/LN$'19?X7'U^Z??%:\T,=Q`\,R!XY%*LIZ$'J*37
M,K/=%1FJ<KKX7^0L,J3PI-$X>.10RL.A!Z&GUSOA+S+!;S0)F+-ILN(6/5H6
MY0_AR/PKHJJ+NKF=2/+)H****H@*!10*`/GG5]1EU75[J^E))FE9@#_"N>!^
M55%1I'5$4LS$!0.Y/2O5=;^%UG?W;W6GWC6;2,6>-DWIDG/'0CZ58\,_#FTT
M6\6^O+G[9<1G,8V;40^N.YKS?J]1RU/IEF6'C2]W?L<S\1M#UG1/AY9+I>H?
M9K.R4?;HD8H\SL1SD=1DGBO./AYX1B\:^(WL+FZ>"&.%II&0`LV"!@9^M>W?
M%L?\6VU/_MG_`.C%KRKX,ZE9:/XDU"_U&Y2VMHK!M\CG@9=`*]%*RLCYN4G)
MN3W9H^/_`(16WAK09-9TF]GFCMR/.BGP2%)QD$`="1Q6A\'O%=WK(O/"6K32
M7$#VS&!V8[U7HR;NN,'(],4_XE_%+1-5\-SZ)HDKW4ET0LDVPJB*""<9Y).*
M;\$O!]];7DOB2^A>"%H3%:JXP9-Q!+8],#`]<TR3@/B%X;L_"GBV?2K&25X$
M1'4RD%AN&<9%>P_"GPMIF@^&(?$*S2^??VH>=I'PB*"3P/;U->:_&G_DHUS_
M`-<(O_0:[/6=4DTO]GVP$3;7NX([?(]&)+?H"/QH`Y#QS\2=6\7:H=,T>2:#
M3C)Y<44)(>X.<`MCGGLM='HGP&\^Q2;7-5DAN'&3#;H#L]BQZGZ"N:^"^F)J
M'CV.>5`RV4#SC/\`>X4?^A9_"OHR@#YX\:?"[5/!,(UG3+Z2ZM(F&Z5`8Y8#
MV)P>F>XKL_A1\2KC79?[!UN7S+U4+6]P>LP'56_V@.<]^:]+U"RBU+3KFQG4
M-%<1-&X/H1BOD_3[J?P]XE@N8V*S6-T#D?[+8/Y\T`?7-%-C<21K(O1@"/QI
MU`'SS\9=,U73O$:37VK27MO>EY+>)B0(%!^[CIWZBO6?A82?AOH^?^>;_P#H
M;5Y]^T!_R$=%_P"N,O\`-:Z#PSXVTKP9\,/#\NIK<,+E9%001[NCG.<D`=:`
M/1[RV%W;-"3MS@@^A!R#^8J>N%T3XN^'->U>WTNTAOUGN6VH7A&W/OACBM[Q
M/XPT7PE:+/JMSM:3/EPH-TDGT']3Q0`^YB^S^*K*[7@74#V\GN1\Z_R:MFO)
MI?CCX>NKNW\W2]11(9=ZNI0GH1R,^A-=%J'Q<\*Z?8VEXL]Q=QW8.WR(\E",
M9#`D8//2DE8J3ND=O17`:=\9O#&IZE;V$,.H+)<2+&A:$8!)P,X8FM#Q1\3-
M"\):H--U&.\><QB3]S$"H!Z<DBF2=?0*X_1?B;H6O6ES/91W8-L5#))$%+9!
M/!SC@*2?2NATK5X=51S&C1NGWD;!XR1D$=1D$?4&@"_1110!QOQ:_P"2;:I_
MVS_]&+7DWP>T:PU_7=2TW4H!/;2V)W(21R'0@@CH0:].^,>IV5KX$N[&:YC2
MYN]GDQ$_,^'4G`]`*\[^!4\<7C6XC>15:6R94!.-QW*<#\*`.B\;?!K2+30;
MG4=!:>&>TC,K0R/O610,D#/(.*P/A)X[U"QU^VT"]N'GT^[/EQ+(V3"_\.TG
ML>F/>O7?'.O6>@>$[^>[E57D@>*&,GF1V!``'XU\_?#33)]4\?:4D*%E@F$\
MC#^%5YR?T'XT`:GQH_Y*+<_]<(O_`$&ND\5P/+\`="D49$+0LWT.X?S(KFOC
M1_R46Y_ZX1?^@UZMX?T6+Q%\&[+292%%S8!58_PMG*G\"!0!YU\!YTC\8WD+
M'#2V3;?P937OU?*VB7]_X!\;17%U`Z3V,Q2>$\%E/#`?4'(/TKZ8T;7]+U^Q
M2\TR]BN(G&?E8;E]F'4&@#0)"@DG`')-?(6HM]MUVZ>+D3W+E,=\L<?SKZ`^
M)GQ`L/#^AW.GV=U'-JES&8TCC8$P@\%FQTXZ#UKRWX3^$9?$7BF*]FB)T_3W
M$LK$<,XY5/SY/L*`/2M>^+6F^$=4.ASZ;=7$MK%&)'1E`W%0<<_6LS_A?^E?
M]`.\_P"_JUWVI^#?#>LWK7NI:/;7-PP`:1UY('3-5/\`A6_@W_H7K/\`[Y/^
M-`'E'QDU>'7K;PUJMNCI%=6LDBJ_5<D<&LF3Q7-K7A+0O`VG[(59@ES--@`N
M9"5`/91D$G_)W_CM:V]C<Z#:6L*0P0VTBQQH,!0"N`*YO5?`TD7P_P!*\5V"
MNZ2(1>)G.P[R`X]N`#Z4`>\^$O!^F>$=)BM+2)&F`S-<LHWR-W.>P]!7S_JE
MW<^._B2$FE;;=WHMXQG_`%<6[``_#GZUZM\)O'W_``D6G#1-3ESJ5JGR.QYG
MC'?_`'AW_/UKQV]M'\,^.YK:],L*VUV0[Q\,(R?O+[[3D4`>D_$S6O!6F>&)
M/#&FVEM/>IM6/[.@_P!&(/)9_P"][=>>:I?"[P'J&H:/JW]L6K0:=J-L(X%E
M7YC)GB10>1CU[YKK_!OPT\*:+;QZNLZ:N[#S([N;'EJ.Q"]!]3^E;ND^/-`U
MOQ%/H6G7+7%Q`A<R*N8VQ@$!N^,B@#P[X?W[>#?B0EKJ4:J#*UG.7'W"3@,#
MVY`Y]#7;_&Z]^W7&C^&;.-)+RYE$A^4%@"=J#/49))_"L3XX^&_L&NV^OP)M
MBOALE([2J.#^*_R-2?"Z*]\8^.Y?$NKL)?[-@4!B,#?MVK^@)^M`'J5OX/L[
M7PS::-;;8?LR`>8$SYAVX;<.^[)K0T?1QI:N6D5W8!55%VI&@)(51DG&6/4U
MS6I_%'2+*[:WMK>>]"'#21D*I/L3UK9\-^+]-\3>8EKYD4\8W/#*,,!ZC'!%
M9JK!NR9T2PU:$.>478WJ***T.<YGQCX#TGQK!$+\RPSP`B*>(_,H/4$'@BO.
M;GX!W\4V_3_$$)`.5,L+(P_$$U[96;XCD>+PSJDL3LCI9RLK*<%2$."#0!Y/
M#\"=5NIU?5?$<;*.I1&D;'MN(KT3P]X$TGPOH]Q8:698YKJ,I+>D@S$XP"#V
MQG(`KAM0U7Q#%IO@>YTJYFFNAI\ES-"TC'[4$1&96_O$C.,UO>%[V'QKJ/B;
M9J%V+"X^RM"89V1H<QY(4C[IR,'%`'/S_`62YF::;Q1)*['EY+8LQ^I+UU_@
M/P#+X*-QNUN>_CF4*L++MCCP<Y`R>:S/A]I!DOM8O9M4U2=].U*>UA2:\=TV
M`8&Y3P3SUKG_``;%=ZG;V5S=6GBNY=[DAKN+4,6^!(1G:6S@8YX[&@#O_%O@
M#0_&,0:^B:*Z082ZAX<#T/8CV->;S_`7589V.GZ_;E#WDC9&Q^&:T/%.HQ0>
M-]?;4Y?$365I#`R?V7.R)!E>2_(`R<<_6K&K/XI3X=^&T.I.FK7.H(L<PFR6
M5MY0.R\-QMSVH`J:1\`XDG636=9,T8.3%;1[=W_`C_A7JNE:38:)I\=AIMLE
MM;1#Y40=_4GN?<UQ'A3Q1+XC\=(Y>2$IHY6ZLRQQ#<++M;*^OOZ&L*U\<D_$
M!=8;6XVTZYOFTX6'G?<C``6;;GC+@\^E`'L%%>;>)?#RKX[T6TCU?6(X=6DN
M'N$2_=0-J[@%'\(R>E79KNXTCX@O:Q7%Q-;V?AUI%ADE+;V5^&/JQ`Z]:`,K
MQ)\'+GQ'K=QJ,_B><K*Y:..6'?Y2G^$?,.!]*W?!7P^;PK9WME=ZO)J=G=)L
M^S21[8T'.<`D]<USL.GW]S\/7\;/XDU)=7,#7BLMP1`N"?W?E]-N!BCQ#XDU
MV/7_``_K%AYC(FCB^O+)6.V6/(WX7U`;(^E`$4GP)6'4VN]+\1S6:ART($)+
MQCT#!A^==/XF^&6F>*-.M4O+F8:C;0K$-0`!>7`_C'1O7^M5O"WBB`V/BS79
M+Q[BPM[QI82SD@1^6I"KZ<GIZUD_#3Q-._B!]/O]9347U:V%\BK-O^S2Y.Z+
MKQ\N#CVH`R$^!.K+FW/B:-;4GE5B?G_@.<5Z)X-\!Z1X+MG%D&FNI1B6YEQN
M8>@]![5#X%N[J[N?$@N;B680ZQ+'&'8G8H`PH]![5U9.`2!DT`>:?'#6K&U\
M*1Z1*BRW=[(KQ#O&JGE_Z?B:S;&V/@SX106_^KO]9;S).S!6&?T3`_&LBX\$
M^+_%WQ`&H^(M-:UL?.!D=I%*1PJ<A5Y]/YDT[QIKXU[7&>`_Z';#RK<#I@=6
M_'^6*PKSY8>IWX"A[6LF]EJ<_7<?"B!W\27,X!V1VA5C[EEP/T/Y5P_2O:?A
M[H;:/X<229-MQ>'SG!'('\(_+G\:XL/'FFGV/;S*JH4&NKT.JHHHKU#Y4*@O
MK./4+"XLIBPBN(FB?:<'##!Q^=3T4`8=KX2TZSFT:6)I]VBP-!;9<8*LH4[N
M.3@4[0_"NF>'+S4+G34>,ZC*)98RWRJ1G[H[#DUM4F,T`<SX2?1%GU>WTR2X
M$\EX\]W%<##J[<$@?W>*KV/PZL]-1(K+7M=@A1]ZPQWN$R3D\8Z$U'XP\/WD
M5VGB70"4U&W'[V-1_KD^G<X[=Q6CX5\867B6W"@B"]0?O;=CS]5]1_*LE/7E
MEN=,Z*</:4]5U\BMJRZ-X=U:^U2_M;R6/5XTBNI`GF0HJ@J`0.1D&FZ1X;\.
MW6C:=::=J4MW::?=B[M@)PQC89PO3.WD\&NK=%D0HZAE88*D9!KE=2^'6BWD
MIN+,S:9<'G?:MM&?]W_#%5+F6JU(@J4E:5T^^_X%W_A#-*37-0UF`S6]WJ-N
M;>=HF`&#C+`8X;@<U%)X!\.R>&QH/V)5@6,()E51-P<[M^.N:Q)/!/BVW^6R
M\72L@Z"1G!_F:J2^!/&%Y\MWXD#+WS-(?TXJ'4E_*;K#TG_R]7W,WM>F\-Z9
M>Z7J.I:D[7>DHZP(L@9Y-R[3N4=3@>U84?C3P[=>*5UB+3]4FOWMOLBQ*JLK
M)NW?=SUS4EC\)+=7#ZAJDDOJL*;<_B<FNRTCP[I6A1[=/LTB8C!D/+M]6/-)
M>UD^R*DL)3C97D_N1SD'PWT>Y@4-)JMKI\K^<^D&ZQ`&)S@J.V>P.*Z-M`L6
MUR#5]K":"U:U1`1Y?ED@XQCVK3HK<X#E(OASH4&C7FD0FYCLKVZ%S+$L@QD$
M'8./N\#BM"\\(Z/=7EA>1VRVD]A-YL3VJK&3Q@JV!R".U;=%`'*-\/K,7UW=
MVNM:U9F\G:>6.VN]B%SU.,5U*C:H7).!C)ZFAW6-"[L%51DDG``KS;QC\1@Z
MR:=H4G7Y9+L?R3_'\JB=2,%=F]##SKRY8(?\1/&2A)-"TV7+'Y;J53T']P>_
MK^5>:4O4Y/7UK:\,>&+OQ+?^5$#';1D>=.1PH]!ZGVKS)2E5D?44J=+"4M]%
MNS1\!>%FU[5!=W,?^@VK`MD<2/V7^IKV<#`Q573=.M=*L(K*SB$<,0PH]?<^
MI-6A7HTJ:IQL?-XO$O$5.;IT"BBBM3D"BBB@`HHHH`*X?Q9X#-Y<'5]"?[+J
M"'>R*VT2'U![-^AKN**B4%)69K2JSI2YH,\TT;XDW6G3G3_$UK(LD9VM,J8=
M?]Y>_P!17?Z=JUAJT`FL+N*X3_8;)'U'454UWPSI?B&'9?6X,@'R3)PZ?0_T
M-><ZI\/->T.<W6CSO=(O(:%MDJ_AW_"L6ZE/S1VJ.&Q&SY)?@>NT5XS:?$/Q
M/I4GD7;K<%."EU%A_P`Q@UO6OQ=3`%YH[@]S#,"/R(IK$4WOH*>6XB.ROZ,]
M(HKB(_BMH3#]Y;7L9_ZY@_UIY^*GAT#A+T_]L1_C5^VI]S#ZGB/Y&=I17`3_
M`!;TU1_H^F74I[;V5/\`&L:]^*^JS`K9V-O;#LSDR'^@J7B*:ZFD,OQ,OLV/
M5R0`2>`.YKF=<\?Z)HP:-9_MER/^64!S@^[=!7D^I^)-:UC(OM1FD0_\LU.U
M/R'%98'10.3T`K">*?V4>A1RE+6K+[C?\1>,M5\1$QS2>1:YXMXCA3_O'^*L
M#@5T.C>!M>UDJR6AMH#_`,MKCY1CV'4UZ+X?^'FDZ,5GN!]NNEY#RK\JGV7_
M`!S64:52J[LZZF+PV%CR0^Y'#^%O`%]KK)<WH>SL>NXC#RC_`&1V'N:];T_3
MK32[*.SLH5AAC&`J_P`SZGWJR*6NZG2C36AX.)Q=3$/WMNP4"B@5J<@44M%`
M"44M%`"44M%`"44M%`"48I:*`*=_I.GZI'LOK.&X'_31`2/H>U<Q??"[0+DE
MK<W%FQ_YYR;E_)LUV=%1*$9;HVIUZM/X)-'F-Q\(I03]EUA2.PEAQ^H-53\)
M=6SQJ5F?P?\`PKUBBLWAZ;Z'4LRQ*^U^"/)_^%2ZM_T$;+\G_P`*F@^$5X3_
M`*1J\*C_`*9PD_S(KU*BE]6I]@>98E]?P1PMG\)]'A(-W=W5T1V!"#].?UKI
M=-\,Z-I.#9:=!$P_CV[F_,\UJT5K&G".R.:IB:U3XI-B8HI:*LP$HI:*`$HI
%:*`/_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
